Gleolan

5-aminolevulinic acid hydrochloride

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Gleolan, covering 2017-06-06 to 2025-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) [Phase 3]